geron
Shares of Stem-Cell Companies Down After Court Ruling
3:15PM 8/24/2010
Companies involved in researching medical techniques using stem cells saw shares tumble across the board Tuesday, a day after a federal court ruled to block government funding for stem cell research.
The Food and Drug Administration cleared the way on Friday for California biotech firm Geron to begin human clinical trials of its experimental embryonic stem cell-based therapy to heal spinal cord injuries in paraplegic patients. Geron claims this is the first such trial in humans.
Geron to Test Embryonic Stem-Cell Therapy After FDA Lifts Clinical Hold; Shares Soar
8:30AM 7/30/2010
Pharmaceutical company Geron announced that the U.S. Food and Drug Administration has lifted the clinical hold it had placed on the company's new drug application, allowing it to proceed with a clinical trial of GRNOPC1 in patients suffering from acute spinal cord injury.
Pfizer Branches Out with Stem Cell Therapy Investment
6:45PM 12/21/2009
Long an old-line drug company, Pfizer is looking increasingly like a new biotech these days, especially after licensing a stem cell therapy. Athersys' MultiStem is a therapy that consists of a special class of stem cells obtained from the bone marrow of healthy, adult donors to treat inflammatory bowel disease.
American trio share Nobel prize for hot area in pharma research
4:15PM 10/05/2009
The Nobel Prize for Medicine was won by three American scientists Monday. The trio won the coveted award for answering some of the most basic questions in life, further deciphering one of our building blocks -- the human cell.
The three Americans joining the long list of Nobel Laureates in their...
It's not easy being first. Biotech company Geron (GERN) had to wait more than a year before getting the green light from federal regulators in January to begin the first study using human embryonic stem cell-based therapies in humans. The early-stage trial is looking at the safety of its drug...
Geron Corp (GERN) shares, which dropped as much as 15 percent earlier today, declined over 10 percent by midday trading after regulators delayed clinical trials on its spinal cord injury treatment.
The stem cell research company today announced that the FDA has placed a clinical hold on its...
Stem cell funding clearance lifts biopharma companies
10:30AM 3/11/2009
On Monday, President Barack Obama signed an order lifting restrictions on federal funding of human embryonic stem cell research. Despite many beliefs to the contrary, no ban on stem cell research exists; only a ban on its public funding. In 1996 Congress banned public funding on the creation of new...
More Stories
Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.10 | -0.09 -1.04% | 158.19M | |
| 2.20 | +0.26 +13.14% | 95.52M | |
| 18.90 | -0.24 -1.23% | 26.45M | |
| 12.41 | -0.28 -2.21% | 25.99M |
% Gainers
| 32.62 | +8.72 +36.49% | 14.25M | |
| 89.53 | +13.14 +17.20% | 9.05M | |
| 2.20 | +0.26 +13.14% | 95.52M | |
| 10.52 | +1.12 +11.91% | 2.68M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Bernanke: Weak housing has hurt consumer...
- Turbo-traders take Bank of America for a ride
- Greek PM vows to rescue bailout deal
- Stocks fall sharply as Greek deal is held up
- Trade deficit widens to $48.8 billion in...
- Feds investigate door fires in 2007 Camrys,...
- NYSE Euronext profit down on blocked merger...
- Obama call for manufacturing revival a tough...
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
- 2011 Trade Deficit Hits 3-Year High, Over $550 Billion
- Today’s Best Market Rumors (2/10/2012) Apple iPad, Google Entertainment
- Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF, TRLG)
- Morning Wire — US Stock-Index Futures Down Sharply
Follow Us
